BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $20
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue (NYSE:TBI) but has lowered the price target from $21 to $20.
July 26, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TrueBlue's price target has been lowered from $21 to $20 by BMO Capital, though the Outperform rating is maintained.
The lowering of the price target by BMO Capital could potentially create a negative sentiment among investors, but the maintained Outperform rating suggests that the analyst still sees potential in the stock. This mixed signal could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100